EBUS-TBNA found safe and effective
An interview with Daniel Culver, DO
An important biomarker in left heart failure
Younger patients respond better to endothelin receptor blockers
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Findings from ADHERE registry should help guide patient selection
Making lung transplant an option in complex cases
Creating a sleep biophysiologic repository, and studying OSA/QT prolongation links
Increase signals disease progression
When conventional ventilatory therapies aren’t enough
An aggressive strategy falls short
Advertisement
Advertisement